Women who experience gestational diabetes during pregnancy are at a significantly higher risk of developing type 2 diabetes and cardiovascular issues, such as heart disease, in the years following childbirth. Studies suggest these mothers also face an elevated likelihood of mental health problems, including depression, especially within high-risk groups, such as those of non-European descent and those with a history of gestational diabetes.
Given these risks, it is crucial that postpartum care for these women focuses on ongoing health monitoring. Regular screenings for blood sugar levels, cardiovascular health, and mental wellbeing should be prioritized. Additionally, providing guidance on diet and physical activity remains essential in the postnatal period.
Support for breastfeeding is also critical, as women with gestational diabetes often experience difficulties, such as delayed milk flow, and are less likely to breastfeed compared to women without the condition. Breastfeeding has been shown to lower the risk of progressing to type 2 diabetes.
While current guidelines recommend screening for blood glucose abnormalities in the first few months after birth, evidence suggests that such care often falls short. A 2018 study in the UK found that women with gestational diabetes felt their care dropped off significantly after childbirth, with many reporting they were effectively abandoned by the healthcare system. Similarly, a 2024 New Zealand study found that mothers interviewed five years after giving birth expressed dissatisfaction with the lack of support for their health post-gestational diabetes.
Our team conducted a review of 26 clinical practice guidelines from 22 countries, including New Zealand, to assess the adequacy of current recommendations for women who experience gestational diabetes. The findings highlighted significant gaps in care. For example, while screening for diabetes within three months of delivery is standard, a New Zealand study revealed that only about half of women received this check-up within six months. This points to a major gap in follow-up care.
Efforts to improve screening attendance, such as sending reminders or combining screenings with routine postnatal checks, could help more women take part in essential health evaluations. However, our review found that few guidelines address methods to boost screening participation.
The need for mental health screenings is another overlooked area. Despite the increased risk of postpartum depression, mental health screenings for women with gestational diabetes are rarely included in clinical guidelines. Our research from 2022, based on randomized trial data, showed that approximately 20% of women with a history of gestational diabetes reported symptoms of anxiety or depression six months after childbirth.
Implementing routine mental health assessments for all women with gestational diabetes is essential for improving their overall care. In addition, healthcare providers should offer counseling on the long-term risks associated with gestational diabetes, encouraging women to engage in screenings, maintain healthy lifestyles, and continue breastfeeding.
By closing these care gaps, we can improve both the short- and long-term health outcomes for women who experience gestational diabetes.
Related topics:
Study Links Fasting Plasma Glucose Levels to Diabetes Risk
FDA Warns of Missed Alerts on Smartphone-Linked Diabetes Devices
